Skip to main content

Advertisement

Table 1 Examples of NCCAs related studies

From: Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?

  Ref. #
(I) General description and classification of NCCAs Wolman SR et al. (1984). Can Genet Cytogenet 16: 49-64 [22]
Casalone R et al. (1992). Hum Genet 90(1–2): 71-8 [86]
Mandahl N et al. (1994). Genes Chromosomes Cancer 9(3): 207-15 [87]
Atkin NB et al. (2003). Cytogenet Cell Genet 101(2): 99-102 [25]
Roschke AV et al. (2003). Cancer Res 63(24): 8634-47 [45]
Heng HH et al. (2006). J Cell Biochem 98: 1424-35 [17]
Heng HH et al. (2006). Genome 49: 195-204 [18]
Mitelman F (2006). NCI, NIH, USA [42]
Bayani J et al. (2007). Semin Cancer Biol 17(1): 5-18 [15]
(II) Variable forms of NCCAs have been reported
 Various numerical/ structural aberrations Erenpreisa J et al. (2005). Cell Biol Int 29(12): 1005-11 [88]
Erenpreisa J et al. (2010). Oncogene 29(40): 5447-51 [89]
 Chromosome fragmentations (C-Frag) Stevens JB et al. (2007). Cancer Res 67 (16): 7686-94 [90]
 Sticky chromosomes Heng HH et al. (2013). Cytogenet Genome Res 139(3): 144-57 [66]
 Chromosome bridge Gisselsson D (2001). Atlas Genet Cytogenet Oncol Haematol 5(3): 236-43 [91]
 Defective mitotic figures (DMF) Heng H et al. (1988). Mutat Res 199(1): 199-205 [32]
Smith L et al. (2001). Proc Natl Acad Sci U S A 98(23): 13300-5 [92]
 Genome/ karyotype/ chromosome chaos Heng HH (2006). J Cell Physiol 208: 461-72 [16]
Duesberg P (2007). Sci Am 296(5): 52-9 [39]
Heng HH (2007). FASEB: Nuclear Structure and Cancer [55]
Liu G et al. (2014). Cell Cycle 13(4): 528-37 [62]
 Karyoplast budding Walen KH (2005). Cell Biol Int 29(12): 1057-65 [93]
 Giant nuclei Walen KH (2010). Cell Biol Int 34(8): 867-72 [94]
Heng HH et al. (2013). Cytogenet Genome Res 139(3): 144-57 [66]
Liu G et al. (2014). Cell Cycle 13(4): 528-37 [62]
Zhang S et al. (2014). Oncogene 33(1): 116-28 [69]
(III) Mechanism of NCCAs Heng HH et al. (2006). J Cell Physiol 208: 461-72 [16]
Heng HH et al. (2011). Genomics 98(4): 242-52 [49]
Vincent MD (2011). Adv Cancer Res 112: 283-350 [95]
Stepanenko AA et al. (2012). Biopolymers and Cell 28(4):267-80 [96]
Huang S (2013). Cancer Metastasis Rev 32(3–4): 423-48 [97]
Duesberg P & McCormack (2013). Cell Cycle 12(5):783-802 [98]
Horne SD et al. (2014). Front Genet 134(9): 2074-87 [65]
Horne SD et al. (2015). eLS: 1-9 [12]
(IV) Significance of NCCAs; they are linked to:
 Chromosomal instability (CIN) Barrios L et al. (1991). Hum Genet 88: 39-41 [28]
Gisselsson D et al. (2001). Proc Natl Acad Sci U S A 98(22): 12683–8. [99]
Ye C et al. (2007). Cytogenet Genome Res 18: 237-46 [11]
Foster N et al. (2009). Cytogenet Genome Res 127(1): 9-20 [38]
Ye C et al. (2009). J Cell Physiol 219: 288-300 [59]
Heng HH et al. (2013). Cytogenet Genome Res 139(3): 144-57 [66]
Jackson TR et al. (2013). Cell Cycle 12(3): 430-41 [70]
 Gene defects Shen KC et al. (2005). Cancer Res 65: 8747-53 [9]
Heng HH et al. (2006). J Cell Phyisol 208: 461-72 [16]
Sharpless NE et al. (2001). Mol Cell 8(6): 1187-96 [46]
 Environmental stress Stevens JB et al. (2011). Cell Death Dis 2: e178 DOI: 10.1038/cddis.2011.60. [100]
 Disease conditions/ prediction, as well as normal tissue/aging processes Hsu TC (1983). Hereditas 98: 1-9 [33]
Biesterfeld S et al. (1994). J Clin Pathol 47(1): 38-42 [101]
Spitz MR et al. (1994). Cancer Detect Prev 18: 299-303 [102]
Hagmar L et al. (1998). Recent Results Cancer Res 154: 177-84 [31]
Bonassi S et al. (2000). Cancer Res 60: 1619-25 [29]
Karashima T et al. (2000). Cancer Genet Cytogenet 120(2): 148-54 [103]
López de Mesa R et al. (2000). Cancer Genet Cytogenet 121(1): 78–85. [104]
Kasahara K et al. (2002). Cancer Genet Cytogenet 137(1): 59-63 [105]
El-Zein R et al. (2005). Cancer Epidemiol Biomarkers Prev 14: 748-52 [30]
Kolusayin Ozar MO et al. (2005). J Exp Clin Cancer Res 24: 217-22 [34]
Petersen I et al. (2009). Lung Cancer 65(3): 312-8 [106]
Fenech M (2011). Mutagenesis 26(1): 63-7 [107]
Heng HH et al. (2016). Curr Genomics (submitted) [108]
 Chemotherapy/radiation treatment (and they occur in the development of resistance) Scott D et al. (1999). Int J Radiat Biol 75: 1 [36]
Duesberg P et al. (2007). Drug Resist Updat 10(1–2): 51-8 [40]
Heng HH et al. (2010). Curr Drug Targets 11: 1304-16 [56]
 Evolutionary potential (both in vitro and in vivo) Rancati G et al. (2008). Cell 135(5): 879-93 [109]
Heng HH et al. (2009). Bioessays 31(5): 512-25 [48]
Pearse AM et al. (2012). Cancer Genet 205(3): 101-12 [110]
Potopova TA et al. (2013). Cancer Metastasis Rev 32(3–4): 377-89 [111]
Stepanenko A et al. (2015). Mutat Res 771: 56-69 [58]